Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tora S Solheim"'
Autor:
Lisa Heide Koteng, Kari Sand, Ingvild Paur, Asta Bye, Bente Ervik, Tora S. Solheim, Inger Ottestad, Trude R. Balstad
Publikováno v:
Clinical Nutrition Open Science, Vol 58, Iss , Pp 289-301 (2024)
Summary: Background and aim: Patients with cancer are at high risk of malnutrition, yet relevant ICD-10 codes for malnutrition are underutilized in cancer clinics. Understanding oncologists' perspectives is crucial for optimizing malnutrition diagnos
Externí odkaz:
https://doaj.org/article/9fbe746d9fc8413cb0ac0d0e75de877d
Autor:
Robin Mjelle, Are K. Kristensen, Tora S. Solheim, Ganna S. Westvik, Hege Elvebakken, Eva Hofsli
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Metastatic colorectal cancer (mCRC) presents significant challenges in clinical management due to its heterogeneity and variable response to treatment. In this study, we conducted comprehensive small RNA (sRNA) sequencing analyses to identif
Externí odkaz:
https://doaj.org/article/416e2b51900c496089e51281a8b66919
Autor:
Marianne J. Hjermstad, Gunnhild Jakobsen, Jann Arends, Trude R. Balstad, Leo R. Brown, Asta Bye, Andrew J.S. Coats, Olav F. Dajani, Ross D. Dolan, Marie T. Fallon, Christine Greil, Alexandra Grzyb, Stein Kaasa, Lisa H. Koteng, Anne M. May, James McDonald, Inger Ottestad, Iain Philips, Eric J. Roeland, Judith Sayers, Melanie R. Simpson, Richard J.E. Skipworth, Tora S. Solheim, Mariana S. Sousa, Ola M. Vagnildhaug, Barry J.A. Laird, the Cancer Cachexia Endpoints Working Group
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 3, Pp 794-815 (2024)
Abstract The use of patient‐reported outcomes (PROMs) of quality of life (QOL) is common in cachexia trials. Patients' self‐report on health, functioning, wellbeing, and perceptions of care, represent important measures of efficacy. This review d
Externí odkaz:
https://doaj.org/article/7a15d61b7a0c4d80b36bc24f394b913a
Autor:
Michael S. Yule, Joshua Thompson, Khachonphat Leesahatsawat, Mariana S. Sousa, Stefan D. Anker, Jann Arends, Trude R. Balstad, Leo R. Brown, Asta Bye, Olav Dajani, Marie Fallon, Marianne J. Hjermstad, Gunnhild Jakobsen, James McDonald, Josh McGovern, Eric J. Roeland, Judith Sayers, Richard J.E. Skipworth, Inger O. Ottestad, Iain Philips, Melanie R. Simpson, Tora S. Solheim, Ola Magne Vagnildhaug, Donald McMillan, Barry J.A. Laird, Ross D. Dolan, the Cancer Cachexia Endpoints Working Group
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 3, Pp 853-867 (2024)
Abstract Regulatory agencies require evidence that endpoints correlate with clinical benefit before they can be used to approve drugs. Biomarkers are often considered surrogate endpoints. In cancer cachexia trials, the measurement of biomarkers featu
Externí odkaz:
https://doaj.org/article/b91388b921c54b20be4595865bc85c5f
Autor:
Leo R. Brown, Mariana S. Sousa, Michael S. Yule, Vickie E. Baracos, Donald C. McMillan, Jann Arends, Trude R. Balstad, Asta Bye, Olav Dajani, Ross D. Dolan, Marie T. Fallon, Christine Greil, Marianne J. Hjermstad, Gunnhild Jakobsen, Matthew Maddocks, James McDonald, Inger O. Ottestad, Iain Phillips, Judith Sayers, Melanie R. Simpson, Ola M. Vagnildhaug, Tora S. Solheim, Barry J.A. Laird, Richard J.E. Skipworth, the Cancer Cachexia Endpoints Working Group
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 3, Pp 816-852 (2024)
Abstract Significant variation exists in the outcomes used in cancer cachexia trials, including measures of body composition, which are often selected as primary or secondary endpoints. To date, there has been no review of the most commonly selected
Externí odkaz:
https://doaj.org/article/97fbbcfba63e4845963cae99e9a6f886
Autor:
Ola Magne Vagnildhaug, Trude R. Balstad, Inger Ottestad, Asta Bye, Christine Greil, Jann Arends, Vickie Baracos, Leo R. Brown, Olav F. Dajani, Ross D. Dolan, Marie Fallon, Eilidh Fraser, Aleksandra Grzyb, Marianne J. Hjermstad, Gunnhild Jakobsen, Stein Kaasa, James McDonald, Iain Philips, Judith Sayers, Melanie R. Simpson, Mariana S. Sousa, Richard J.E. Skipworth, Barry J.A. Laird, Tora S. Solheim, the Cancer Cachexia Endpoints Working Group
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 15, Iss 2, Pp 513-535 (2024)
Abstract There is no consensus on the optimal endpoint(s) in cancer cachexia trials. Endpoint variation is an obstacle when comparing interventions and their clinical value. The aim of this systematic review was to summarize and evaluate endpoints us
Externí odkaz:
https://doaj.org/article/6596804cf0344f1aac4edf86642b3db0
Autor:
James McDonald, Judith Sayers, Stefan D. Anker, Jann Arends, Trude Rakel Balstad, Vickie Baracos, Leo Brown, Asta Bye, Olav Dajani, Ross Dolan, Marie T. Fallon, Eilidh Fraser, Christine Griel, Aleksandra Grzyb, Marianne Hjermstad, Mariam Jamal‐Hanjani, Gunnhild Jakobsen, Stein Kaasa, Donald McMillan, Matthew Maddocks, Iain Philips, Inger O. Ottestad, Kieran F. Reid, Mariana S. Sousa, Melanie R. Simpson, Ola Magne Vagnildhaug, Richard J. E. Skipworth, Tora S. Solheim, Barry J. A. Laird, the Cancer Cachexia Endpoints Working Group
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 5, Pp 1932-1948 (2023)
Abstract In cancer cachexia trials, measures of physical function are commonly used as endpoints. For drug trials to obtain regulatory approval, efficacy in physical function endpoints may be needed alongside other measures. However, it is not clear
Externí odkaz:
https://doaj.org/article/631dce5bbeae444e8aa791e121b8775f
Autor:
Knut Johannessen, Erik Magnus Berntsen, Håkon Johansen, Tora S. Solheim, Anna Karlberg, Live Eikenes
Publikováno v:
European Journal of Hybrid Imaging, Vol 5, Iss 1, Pp 1-12 (2021)
Abstract Background Patients with metastatic cancer to the brain have a poor prognosis. In clinical practice, MRI is used to delineate, diagnose and plan treatment of brain metastases. However, MRI alone is limited in detecting micro-metastases, deli
Externí odkaz:
https://doaj.org/article/fc593e5e7dfe4b92a7775be9600bfaa1
Autor:
Mjelle, Robin, Kristensen, Are K., Tora S. Solheim, Westvik, Ganna S., Elvebakken, Hege, Hofsli, Eva
Publikováno v:
Molecular Cancer; 6/27/2024, Vol. 23, p1-9, 9p
Autor:
Jon Arne Sandmæl, Asta Bye, Tora S. Solheim, Trude R. Balstad, Lene Thorsen, Eva Skovlund, Stein Kaasa, Jo‐Åsmund Lund, Line Oldervoll
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 5, Iss 2, Pp 330-338 (2020)
Abstract Objective Physical rehabilitation programs hold the potential to mitigate deterioration in health‐related quality of life (HRQoL) in patients with head and neck cancer. The objective was to assess development in relevant domains of HRQoL f
Externí odkaz:
https://doaj.org/article/c30075788c7a4baca9a325161b19fcae